2026 Minnesota Allergy Society Annual Meeting
Minnesota Allergy Society is pleased to provide the following opportunities for organizations to promote and educate attendees about their products and services at the 2026 Minnesota Allergy Society Annual Meeting. Whether you are displaying your products in the exhibit space, interacting with physicians at one of the meal functions or gaining brand recognition for your company through program acknowledgements, your message will reach physicians and allied health care professionals.
The Minnesota Allergy Society Annual meeting is a live event held in Edina, Minnesota on Friday evening September 25th and Saturday September 26th. Join us for a new format! Our two-day event that will offer state-of-the-art presentations and discussions regarding advances in allergic diseases, asthma, and immunologic disorders. In addition, allergy/immunology fellows-in-training will discuss challenging cases as well as exciting research updates. We are excited to be able to share the wealth of knowledge and expertise from several Allergist/Immunologist specialists from around the country
Target Audience
- A/I Physicians
- Fellows-in-Training
- Medical Residents & Students
- Advanced Practice Providers
- PhDs
- PharmaDs
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply the updated risk stratification framework, including cofactors, serum tryptase, and mast cell disease, to clinical decision-making about VIT candidacy
- Describe key updates to venom immunotherapy protocols, including build-up schedules, maintenance dosing, and duration of treatment
- Provide a brief clinical overview of eosinophilic esophagitis (EoE)
- Describe the major neuroimmune pathways involved in itch transmission and sensitization
- Evaluate the validity of medical research findings by recognizing key methodological limitations, sources of bias, and factors that influence the reliability and applicability of study results
- Select appropriate biologic therapies for patients with unified airway disease based on underlying inflammatory pathways, clinical presentation, and current guideline recommendations.
Summary
- 5.25 AttendanceAttendance credit.
- 5.25 CECE credit.
- 5.25 CMECME credit.
The information disclosed by the speakers, planning committee, and reviewers was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Planning Committee
Nicole M. Chase, MD FAAP FAAAAI
St. Paul Allergy & Asthma
Relevant Relationships: None
Mee Lee Chun Nelson, MD FAAAAI
Southdale Pediatrics Associates Adult & Pedia
Relevant Relationships: None
Thanai Pongdee, MD FAAAAI
Mayo Clinic
Relevant Relationships: None
Faculty
Karla E. Adams, MD FAAAAI
US Air Force
Relevant Relationships: None
Nicole M. Chase, MD FAAP FAAAAI
St. Paul Allergy & Asthma
Relevant Relationships: Cogent, Incyte, Novartis, Regeneron (Advisory Board); Apogee, Aquestive, ARS, Blueprint Medicines, Genentech, Incyte, Novartis, Regeneron, Sanofi (Consultant); MJH (Honorarium/Gift); Kenota, Inc. (Research Grant); Amgen, Blueprint Medicines, Eli Lilly, Genentech, Incyte, Regeneron, Sanofi (Speaker)
Victor Y. Chen, MD
Mayo Clinic
Relevant Relationships: None
Carla M. Davis, MD FAAAAI
Howard University College of Medicine
Relevant Relationships: None
James T. Li, MD PhD FAAAAI
Mayo Clinic
Relevant Relationships: None
Jenny Link, MD
Mayo Clinic
Relevant Relationships: None
Brian J. Lipworth, MD
University Of Dundee
Relevant Relationships: None
Emily C. McGowan, MD PhD FAAAAI
University of Virginia School of Medicine
Relevant Relationships: None
Mee Lee Chun Nelson, MD FAAAAI
Southdale Pediatrics Associates Adult & Pedia
Relevant Relationships: None
Emily E. Nestor, MD, MPH
Mayo Clinic
Relevant Relationships: None
Joshua A. Peterson, MD
Mayo Clinic
Relevant Relationships: None
Thanai Pongdee, MD FAAAAI
Mayo Clinic
Relevant Relationships: None
Cherie Y. Zachary, MD FAAAAI
ACAAI
Relevant Relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Minnesota Allergy Society. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 5.25 Contact Hours
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on September 24, 2027. Requests to claim credit on or after September 25, 2027 will be subject to an administrative fee.
Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:
- Navigate to the AAAAI webpage for credit claiming
- Enter the attendance code received at the live activity
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
Questions
Activity-related questions should be directed to [email protected].
Available Credit
- 5.25 AttendanceAttendance credit.
- 5.25 CECE credit.
- 5.25 CMECME credit.

Facebook
X
LinkedIn
Forward